Type I/type III IFN and related factors regulate JEV infection and BBB endothelial integrity

被引:5
|
作者
Zhang, Ya-Ge [1 ,2 ,4 ]
Zhang, Hong-Xin [1 ,2 ,4 ]
Chen, Hao-Wei [1 ,2 ,4 ]
Lv, Penghao [1 ,2 ,4 ]
Su, Jie [1 ,2 ,4 ]
Chen, Yan-Ru [1 ,2 ,4 ]
Fu, Zhen-Fang [1 ,3 ]
Cui, Min [1 ,2 ,4 ]
机构
[1] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China
[2] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China
[3] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA USA
[4] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Peoples R China
关键词
Japanese encephalitis virus; Human brain microvascular endothelial cells; RNA-Seq; PRRs; IFNs; IFITs; BLOOD-BRAIN-BARRIER; INTERFERON-STIMULATED GENES; CENTRAL-NERVOUS-SYSTEM; JAPANESE-ENCEPHALITIS; IFIT FAMILY; DIFFERENTIAL ROLES; VIRUS-INFECTION; CELLS; REPLICATION; PROTEIN;
D O I
10.1186/s12974-023-02891-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundJapanese encephalitis virus (JEV) remains a predominant cause of Japanese encephalitis (JE) globally. Its infection is usually accompanied by disrupted blood-brain barrier (BBB) integrity and central nervous system (CNS) inflammation in a poorly understood pathogenesis. Productive JEV infection in brain microvascular endothelial cells (BMECs) is considered the initial event of the virus in penetrating the BBB. Type I/III IFN and related factors have been described as negative regulators in CNS inflammation, whereas their role in JE remains ambiguous.MethodsRNA-sequencing profiling (RNA-seq), real-time quantitative PCR, enzyme-linked immunosorbent assay, and Western blotting analysis were performed to analyze the gene and protein expression changes between mock- and JEV-infected hBMECs. Bioinformatic tools were used to cluster altered signaling pathway members during JEV infection. The shRNA-mediated immune factor-knockdown hBMECs and the in vitro transwell BBB model were utilized to explore the interrelation between immune factors, as well as between immune factors and BBB endothelial integrity.ResultsRNA-Seq data of JEV-infected hBMECs identified 417, 1256, and 2748 differentially expressed genes (DEGs) at 12, 36, and 72 h post-infection (hpi), respectively. The altered genes clustered into distinct pathways in gene ontology (GO) terms and KEGG pathway enrichment analysis, including host antiviral immune defense and endothelial cell leakage. Further investigation revealed that pattern-recognition receptors (PRRs, including TLR3, RIG-I, and MDA5) sensed JEV and initiated IRF/IFN signaling. IFNs triggered the expression of interferon-induced proteins with tetratricopeptide repeats (IFITs) via the JAK/STAT pathway. Distinct PRRs exert different functions in barrier homeostasis, while treatment with IFN (IFN-& beta; and IFN-& lambda;1) in hBMECs stabilizes the endothelial barrier by alleviating exogenous destruction. Despite the complex interrelationship, IFITs are considered nonessential in the IFN-mediated maintenance of hBMEC barrier integrity.ConclusionsThis research provided the first comprehensive description of the molecular mechanisms of host-pathogen interplay in hBMECs responding to JEV invasion, in which type I/III IFN and related factors strongly correlated with regulating the hBMEC barrier and restricting JEV infection. This might help with developing an attractive therapeutic strategy in JE.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Type I/type III IFN and related factors regulate JEV infection and BBB endothelial integrity
    Ya-Ge Zhang
    Hong-Xin Zhang
    Hao-Wei Chen
    Penghao Lv
    Jie Su
    Yan-Ru Chen
    Zhen-Fang Fu
    Min Cui
    Journal of Neuroinflammation, 20
  • [2] HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling
    Chandra, Partha K.
    Bao, Lili
    Song, Kyoungsub
    Aboulnasr, Fatma M.
    Baker, Darren P.
    Shores, Nathan
    Wimley, William C.
    Liu, Shuanghu
    Hagedorn, Curt H.
    Fuchs, Serge Y.
    Wu, Tong
    Balart, Luis A.
    Dash, Srikanta
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (01): : 214 - 229
  • [3] Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection
    Lopusna, Katarina
    Benkoczka, Timea
    Luptak, Jakub
    Matuskova, Radka
    Lukacikova, Lubomira
    Oveckova, Ingrid
    Rezuchova, Ingeborg
    CYTOKINE, 2016, 83 : 158 - 170
  • [4] IL-27, a Cytokine, and IFN-λ1, a Type III IFN, Are Coordinated To Regulate Virus Replication through Type I IFN
    Cao, Yanhua
    Zhang, Rui
    Zhang, Wei
    Zhu, Chengliang
    Yu, Yi
    Song, Yu
    Wang, Qing
    Bai, Lan
    Liu, Yingle
    Wu, Kailang
    Wu, Jianguo
    JOURNAL OF IMMUNOLOGY, 2014, 192 (02): : 691 - 703
  • [5] Type I IFN regulate DC turnover in vivo
    Mattei, Fabrizio
    Bracci, Laura
    Tough, David F.
    Belardelli, Filippo
    Schiavoni, Giovanna
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (07) : 1807 - 1818
  • [6] Type I Ifn Enhances Poly(i:c)-Induced Type Iii Ifn Production By Human Alveolar Macrophages
    Brown, J. P.
    Nelson, J. D.
    McCloskey, L.
    Freeman, C. M.
    Curtis, J. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Type I IFN enhances Coxiella burnetii infection
    Hedges, Jodi
    Robison, Amanda
    Christensen, Kelly
    Kimmel, Emily
    Lucas, Erin
    Ramstead, Andrew
    Jutila, Mark
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [8] Pathogenic potential of type I IFN in influenza infection
    Wack, A.
    Davidson, S.
    Crotta, S.
    IMMUNOLOGY, 2013, 140 : 14 - 14
  • [9] IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-λ) genes
    Osterlund, Pamela I.
    Pietilae, Taija E.
    Veckman, Ville
    Kotenko, Sergei V.
    Julkunen, Iikka
    JOURNAL OF IMMUNOLOGY, 2007, 179 (06): : 3434 - 3442
  • [10] Intracellular HCV RNA and extracellular HCV core protein differentially regulate Type I and III IFN signaling within human liver sinusoidal endothelial cells
    Giugliano, Silvia
    Golden-Mason, Lucy
    Stone, Amy
    Gale, Michael
    Shah, Vijay
    Rosen, Hugo R.
    HEPATOLOGY, 2012, 56 : 1105A - 1105A